Summit Master_rgb_png.png
Summit Therapeutics Publishes Scientific Updates to Corporate Website
May 06, 2021 08:00 ET | Summit Therapeutics Inc.
Cambridge, MA, May 5, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that we have updated the scientific and related content on our corporate website with respect to our...
Summit Master_rgb_png.png
Summit Therapeutics’ Rights Offering Nearing Expiration Date; Robert W. Duggan Declares Intention to Fully Oversubscribe in the Rights Offering
May 05, 2021 12:47 ET | Summit Therapeutics Inc.
Cambridge, MA, May 5, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it is nearing the previously-announced expiration date for its rights offering of 5:00 pm Eastern Daylight...
Summit Master_rgb_png.png
Summit Therapeutics Announces Commencement of Rights Offering
April 21, 2021 08:04 ET | Summit Therapeutics Inc.
Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Summit Therapeutics Announces Commencement of Rights Offering Cambridge, MA, April 21, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today...
Summit Master_rgb_png.png
Summit Therapeutics Announces Rights Offering
March 26, 2021 07:00 ET | Summit Therapeutics Inc.
Cambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has approved a rights offering available to all holders of record of the...
Summit Master_rgb_png.png
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020
March 17, 2021 07:00 ET | Summit Therapeutics plc
Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Cambridge, MA, March 17, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on...
Summit Master_rgb_png.png
Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer
November 23, 2020 07:00 ET | Summit Therapeutics plc
Summit Therapeutics Inc.(‘Summit,’ the ‘Company,’ or the ‘Group’) Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer Cambridge, MA, November 23, 2020 – Summit...
Summit Master_rgb_png.png
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020
November 16, 2020 16:05 ET | Summit Therapeutics plc
Summit Therapeutics Inc.(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020 ...
Summit Master_rgb_png.png
Summit Announces Closing of Private Placement of $50 Million
November 06, 2020 16:01 ET | Summit Therapeutics plc
Summit Therapeutics Inc.(“Summit” or the “Company”) Summit Announces Closing of Private Placement of $50 Million Cambridge, MA, November 6, 2020 – Summit (NASDAQ: SMMT) today announces that it has...
Summit Master_rgb_png.png
Summit Announces Agreement For a Fundraising of approximately $50 Million
October 02, 2020 18:40 ET | Summit Therapeutics plc
Summit Therapeutics Inc. (“Summit” or the “Company”) Summit Announces Agreement For a Fundraising of approximately $50 Million Cambridge, MA, October 2, 2020 – Summit (NASDAQ: SMMT) today announces...
Summit Master_rgb_png.png
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020
September 29, 2020 07:00 ET | Summit Therapeutics plc
Summit Therapeutics Inc.(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020 ...